Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Explore clinical trials studying Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) trial results

Active, Not Recruiting

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT04994717

Conditions
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Adventist Health System/Sunbelt, Inc d/b/a AdventHealth Orlando Orlando, Florida, United States
View all 192 locations
View Trial Details